// App-Quantinova.ai

e17008 : A morphological subset of circulating tumor cells in advanced prostate cancer reveals a potential biomarker for clinical outcomes.

Researchers

Presenter

  • Jasmine Jiemei Wang

Principal Investigators

  • Karen Angelica Cavassani

  • Pai-Chi Teng

  • Jie-Fu Chen

  • Yu Jen Jan

  • Gina Chia-Yi Chu

  • Yi-Te Lee

  • Allen Gao

  • Dolores Di Vizio

  • Leland WK Chung

  • Sungyong You

  • Yazhen Zhu

  • Michael Freeman

  • Andre Rogatko

  • Ju Dong Yang

  • Hsian-Rong Tseng

  • Edwin Melencio Posadas

Medical Centers

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, Los Angeles, CA

  • University of Southern California, Los Angeles, CA

  • University of California, Davis Comprehensive Cancer Center, Sacramento, CA

  • California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA

  • Cedars-Sinai Medical Center, Hollywood, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Androgen Tear

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved